Treatment with dimaprit, a specific H2 receptor agonist, reduced plasma TNF levels in mouse models of endotoxin shock (LPS challenge) and hepatitis (LPS plus galactosamine challenge) [41]. This evidence concerns the gene TNF and hepatitis A virus infection.